TELA Bio (TELA) Free Cash Flow (QoQ) (2019 - 2026)
TELA Bio (TELA) Free Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | TELA Bio | 40.12 Mn | 578,641.31 | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.55% |
| Dec 31, 2025 | 16.34% |
| Sep 30, 2025 | 26.05% |
| Jun 30, 2025 | 17.81% |
| Mar 31, 2025 | -16.92% |
| Dec 31, 2024 | 8.33% |
| Sep 30, 2024 | 13.93% |
| Jun 30, 2024 | 27.36% |
| Mar 31, 2024 | -35.27% |
| Dec 31, 2023 | -46.95% |
| Sep 30, 2023 | 34.59% |
| Jun 30, 2023 | 4.20% |
| Mar 31, 2023 | -15.00% |
| Dec 31, 2022 | -22.03% |
| Sep 30, 2022 | 27.55% |
| Jun 30, 2022 | -6.78% |
| Mar 31, 2022 | -11.48% |
| Dec 31, 2021 | -44.57% |
| Sep 30, 2021 | -18.15% |
| Jun 30, 2021 | 34.31% |